FrederickG.HaydenMD

Infectious Disease • Charlottesville, VA

Professor Emeritus, Department of Medicine, University of Virginia School of Medicine

Join to view full profile

Dr. Hayden is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hayden's full profile

Already have an account?

Office
345 Crispell Drive, MR-6
Charlottesville, VA 22908
Phone+1 434-924-5059

Education & Training

University of RochesterFellowship, Infectious Disease, 1976 - 1978
University of RochesterResidency, Internal Medicine, 1973 - 1976
Stanford University School of MedicineClass of 1973

Certifications & Licensure

VA State Medical License 1978 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1992

Publications & Presentations

PubMed

A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of VIR-2482 in Healthy Adults for Prevention of Influenza A Illness (PENINSULA).
Susanna K Tan, Deborah Cebrik, David Plotnik, Maria L Agostini, Keith Boundy
Clinical Infectious Diseases. 2024-10-15
2 citations
Oral Favipiravir Exposure and Pharmacodynamic Effects in Adult Outpatients With Acute Influenza.
Frederick G Hayden, Robert P Lenk, Carol Epstein, Lih Lisa Kang
The Journal of Infectious Diseases. 2024-08-16
4 citations
Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials.
Frederick G Hayden, Robert P Lenk, Lucille Stonis, Catherine Oldham-Creamer, Lih Lisa Kang
The Journal of Infectious Diseases. 2022-11-11

Journal Articles

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe COVID-19
Frederick Hayden, MD, The New England Journal of Medicine
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents
Frederick Hayden, MD, The New England Journal of Medicine

Authored Content

Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory SyndromeOctober 2020

Press Mentions

Mixed Bag for Antiviral Favipiravir in FluMay 31st, 2022
Pandemic Fraud: Fauci Pushed US to Spend $1.5 Billion on Big Pharma Drug That Has No Proven BenefitsJuly 24th, 2021
Covid-19: Lopinavir-Ritonavir Combo Falls Short—AgainOctober 7th, 2020
Join now to see all

Grant Support

Intravenous Zanamir In Experimental InfluenzaNational Center For Research Resources1998–1999
Rimantadine In Treating Influenza A Virus In Adult PatientsNational Center For Research Resources1989
Prophylactic Efficacy Of Interferon-Beta 17 Serine In Naturally Acquired ColdsNational Center For Research Resources1988–1989
Multiple Dose Pharmacokinetics Of Rimantadine In Older VolunteersNational Center For Research Resources1987–1988